Menu

Pending AI

Pending AI has developed a comprehensive discovery platform enabled by artificial intelligence and quantum mechanics, ushering in a new paradigm of medicinal innovation where higher-quality small molecule drugs can be developed in a fraction of the time and cost.

More about us

Make data-driven decisions with

Discipline-scale Datasets

AI is becoming more essential as scientific data is becoming more abundant and more accessible. In order to offer high-quality evidence-based solutions our AI models are trained across massive federated datasets that contain millions of data points. AI-based solutions can then be employed to augment the cognitive abilities of individual scientists and teams to enable them to make more informed decisions in drug design.

4
Billion Compounds
21
Million Reactions
147
Thousand Proteins

Faster Discovery

A platform to accelerate drug discovery

De novo Drug Design

Generative AI provides a way to rapidly generate novel molecules. There has been an explosion in generative models using neural networks. Massive virtual libraries of compounds can be rapidly generated to explore new and exciting areas of chemical space.

Structure-Based Drug Design

Structure based drug design is heavily reliant upon high quality protein structures. Rapidly docking virtual molecules to proteins of interest is a computationally demanding problem.

Contact Us

Reach out for a new project

Send Us A Message

Sending...
Something went wrong. Please try again.
Your message was sent, thank you!

Contact Info

Boston

Pending AI Inc.
1 Broadway, Cambridge,,
Massachusetts,
United States, 02142

Sydney

Pending AI Pty Ltd.
The National Innovation Centre,
Suite 112, 4 Cornwallis St.,
Eveleigh,
NSW 2015, Australia

Email Us

contact@pending.ai